U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced
Primary HTS Code
3004.90.9120
$4641.1M monthly imports
Compare All →
Ruling Age
13 years
Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly
The tariff classification of Vascepa™ imported in dosage form, from the Netherlands
N234077 November 2, 2012 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9120 Ms. Natasha Ling Amarin Pharma, Inc. 1430 Route 206 North, Suite 200 Bedminster, NJ 07921 RE: The tariff classification of Vascepa™ imported in dosage form, from the Netherlands Dear Ms. Ling: In your letter dated October 5, 2012, you requested a tariff classification ruling. The subject product, Vascepa™, is a lipid-regulating agent containing 1 gram of Icosapent ethyl in capsule form, as the active ingredient. Icosapent ethyl is an ethyl ester of the omega-3 fatty acid eicosapentaenoic acid (EPA). Vascepa™ is available by prescription only and it is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with very severe hypertriglyceridemia. The applicable subheading for Vascepa™ imported in dosage form will be 3004.90.9120, Harmonized Tariff Schedule of the United States (HTSUS) which provides for "Medicaments… consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments." The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at (646) 733-3033. Sincerely, Thomas J. Russo Director National Commodity Specialist Division